4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow pegilodecakin: new trials by email Literature Review of pegilodecakin trials Research Report on pegilodecakin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants Pegilodecakin - Healthy Adult Subjects | Phase 1 | Completed | Eli Lilly and Company | 12 | 2018-01-19 | 2026-07-13 |
| A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) Pegilodecakin - Healthy Adult Subjects | Phase 1 | Completed | Eli Lilly and Company | 12 | 2017-12-18 | 2026-07-07 |
| A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) Pegilodecakin - Healthy Adult Subjects | Phase 1 | Completed | Eli Lilly and Company | 24 | 2017-09-05 | 2026-10-02 |
| A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or Cisplatin, FOLFOX (Oxaliplatin/Leucovorin/5-Fluorouracil) - Melanoma, Prostate Cancer | Phase 1 | Completed | Eli Lilly and Company | 353 | 2013-11-15 | 2026-07-09 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Melanoma (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1)
United States (4)